Evidence behind the WHO guidelines: Hospital care for children: What antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV?

Journal of Tropical Pediatrics

Volumn 52, Issue 4, 2006, Pages 235-238

  Nightingale, Scott ^a   Dabis, Francois ^b  

^a JOHN HUNTER HOSPITAL   (Australia)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; NEVIRAPINE; PLACEBO; ZIDOVUDINE;

ADD ON THERAPY; CHEMOPROPHYLAXIS; CHILD CARE; CLINICAL TRIAL; COCHRANE LIBRARY; COUNSELING; DRUG EFFICACY; HOSPITAL CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT FEEDING; INFECTION PREVENTION; INFORMATION RETRIEVAL; MEDLINE; MONOTHERAPY; PRACTICE GUIDELINE; PREGNANT WOMAN; REVIEW; SINGLE DRUG DOSE; TREATMENT DURATION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

EID: 33748096283     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fml033     Document Type: Review

References (24)

1. UNAIDS. AIDS epidemic update. Geneva: UNAIDS/WHO, 2004.
2. Department of Reproductive Health and Research (RHR), World Health Organization. Mother-to-Child transmission of HIV: Geneva. http:// www.who.int/reproductive-health/stis/mtct/index.htm (last accessed 15 June 2006).
3. Brocklehurst P, Volmink J. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. In: The Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, 2002.
4. Leroy V, Sakarovitch C, Cortina-Borja M, et al. Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? AIDS 2005;19:1865-75.
5. Volmink J, Mahlat U. HIV: Mother to child transmission. In: Clinical Evidence. BMJ Publishing Group, London, 2005; 823-33.
6. Ekouevi DK, Tonwe-Gold B, Dabis F. Advances in the prevention of mother-to-child transmission of HIV-1 infection in resource-limited settings. AIDS Reader 2005;15:479-80, 487-93.
7. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Eng J Med 1994;331:1173-80.
8. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 1999;353:773-80.
9. Wiktor SZ, Ekpini E, Karon JM, et al. Short course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: A randomised trial. Lancet 1999;353:781-85.
10. Dabis F, Msellati P, Meda N, et al. Six months efficacy, tolerance and acceptability of a short regimen of oral zidovudine in reducing vertical transmission of HIV in breast-fed children. A double blind placebo controlled multicentre trial, ANRS049a, Côte d'Ivoire and Burkina Faso. Lancet 1999;353:786-92.
11. Leroy V, Karon JM, Alioum A, et al. Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. AIDS 2002;16:631-41.
12. Lallemant M, Jourdain G, Le Coeur S, et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Eng J Med 2000;343:982-91.
13. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, et al. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 2001;285:2083-93.
14. The PETRA study team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa and Uganda (Petra study): A randomised, double-blind, placebo-controlled trial. Lancet 2002;359:1178-86.
15. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
16. Jackson JB, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet 2003;362:859-68.
17. Moodley D, Moodley J, Coovadia H, et al. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Inf Dis 2003;187:725-35.
18. Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004;351:217-28.
19. Dabis F, Bequet L, Ekouevi DK, et al. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. ANRS 1201/1202 DITRAME PLUS Study Group. AIDS 2005;19:309-18.
20. Dorenbaum A, Cunningham CK, Gelber RD, et al. Two dose intrapartum/ newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: A randomised trial. JAMA 2002;288:189-98.
21. Taha TE, Kumwenda NI, Hoover DR, et al. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: A randomized controlled trial. JAMA 2004;292:202-9.
22. Taha TE, Kumwenda NI, Gibbons A, et al. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet 2003;362:1171-77.
23. Gray GE, Urban M, Chersich MF, et al. A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers. AIDS 2005;19:1289-97.
24. Vyankandondera J, Luchters S, Hassink E, et al. Reducing risk of HIV-1 transmission from mother to infant through breastfeeding using antiretroviral prophylaxis in infants (SIMBA study). In: Program and abstracts of the 2nd IAS Conference on HIV Pathogenesis and Treatment; July 13-16, 2003; Paris, France. Abstract LB7. International AIDS Society, Geneva, Switzerland.